PMHS Share Price Performance
Recent PMHS News & Updates
No updates
Polomar Health Services, Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.059
- Gross Margin
- 63.05%
- Net Profit Margin
- -3,291.50%
- Debt/Equity Ratio
- 16.1%
Polomar Health Services, Inc. Competitors
About PMHS
- Founded
- n/a
- Employees
- 3
- CEO
- WebsiteView website
Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker’s nevus, vitiligo, and other common skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.
U.S. Market Performance
- 7 Days: 0.8%
- 3 Months: 15.1%
- 1 Year: 17.5%
- Year to Date: 8.2%
In the last week, the market has stayed flat, however the Energy sector stood out, gaining 3.9%. More promisingly, the market is up 17% over the past year. Earnings are forecast to grow by 15% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading